- Home
- CADL vs HCAT Comparison
CADL vs HCAT Comparison
Compare CADL & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- HCAT
- Stock Information
- Founded
- CADL 1999
- HCAT 2008
- Country
- CADL United States
- HCAT United States
- Employees
- CADL N/A
- HCAT N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- HCAT Computer Software: Programming Data Processing
- Sector
- CADL Health Care
- HCAT Technology
- Exchange
- CADL Nasdaq
- HCAT Nasdaq
- Market Cap
- CADL 306.4M
- HCAT 318.2M
- IPO Year
- CADL 2021
- HCAT 2019
- Fundamental
- Price
- CADL $8.84
- HCAT $4.44
- Analyst Decision
- CADL Strong Buy
- HCAT Buy
- Analyst Count
- CADL 4
- HCAT 11
- Target Price
- CADL $21.00
- HCAT $9.27
- AVG Volume (30 Days)
- CADL 1.4M
- HCAT 1.0M
- Earning Date
- CADL 03-13-2025
- HCAT 05-08-2025
- Dividend Yield
- CADL N/A
- HCAT N/A
- EPS Growth
- CADL N/A
- HCAT N/A
- EPS
- CADL N/A
- HCAT N/A
- Revenue
- CADL N/A
- HCAT $306,584,000.00
- Revenue This Year
- CADL N/A
- HCAT $11.33
- Revenue Next Year
- CADL N/A
- HCAT $9.68
- P/E Ratio
- CADL N/A
- HCAT N/A
- Revenue Growth
- CADL N/A
- HCAT 3.60
- 52 Week Low
- CADL $1.34
- HCAT $3.76
- 52 Week High
- CADL $14.60
- HCAT $9.24
- Technical
- Relative Strength Index (RSI)
- CADL 53.22
- HCAT 34.22
- Support Level
- CADL $7.65
- HCAT $3.85
- Resistance Level
- CADL $8.31
- HCAT $4.64
- Average True Range (ATR)
- CADL 0.67
- HCAT 0.39
- MACD
- CADL -0.05
- HCAT -0.01
- Stochastic Oscillator
- CADL 79.10
- HCAT 28.57
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.